e-5555 and Albuminuria

e-5555 has been researched along with Albuminuria* in 1 studies

Other Studies

1 other study(ies) available for e-5555 and Albuminuria

Article	Year
Dual blockade of protease-activated receptor 1 and 2 additively ameliorates diabetic kidney disease. American journal of physiology. Renal physiology, 2020, 05-01, Volume: 318, Issue:5 Topics: Albuminuria; Animals; Cell Line; Cell Proliferation; Collagen Type IV; Cytokines; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Models, Animal; Drug Therapy, Combination; Endothelial Cells; Fibrosis; Humans; Imines; Inflammation Mediators; Kidney; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Oligopeptides; Pyridines; Receptor, PAR-1; Receptor, PAR-2; Signal Transduction	2020

Article

Year

Dual blockade of protease-activated receptor 1 and 2 additively ameliorates diabetic kidney disease.

American journal of physiology. Renal physiology, 2020, 05-01, Volume: 318, Issue:5

Topics: Albuminuria; Animals; Cell Line; Cell Proliferation; Collagen Type IV; Cytokines; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Models, Animal; Drug Therapy, Combination; Endothelial Cells; Fibrosis; Humans; Imines; Inflammation Mediators; Kidney; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Oligopeptides; Pyridines; Receptor, PAR-1; Receptor, PAR-2; Signal Transduction

2020